Ranolazine

Product manufactured by Micro Labs Limited

Application Nr Approved Date Route Status External Links
ANDA211745 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ranolazine Extended-Release Tablet Is Indicated For The T Re At Ment Of Ch Ron Ic An G Ina. Ranolazine May Be Used With Beta-Blockers, Nitrates, Calcium Channel Blockers, Anti- Platelet Therapy, Lipid-Lowering Therapy, Ace Inh Ib Ito Rs, A Nd An G Iote Ns In Recep Tor B Locke Rs. Ranolazine Extended-Release Tablet Is An Antianginal Indicated For The Treatment Of Chronic Angina. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ranolazine RANOLAZINE ZINC95619101

Comments